Overview

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate clinical safety and pharmacokinetics of Maxmarvil® in healthy postmenopausal women
Phase:
Phase 1
Details
Lead Sponsor:
Yuyu Pharma, Inc.
Treatments:
Alendronate
Calcitriol
Maxmarvil